David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 9.3% |
| 2 | Healthcare | 8.21% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Energy | 7.7% |
| 5 | Technology | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CALL
Biogen
BIIB
$32B
| $66M | 0.09% |
215,900
+33,800
| +19% | +$10.7M |
|
227
PUT
Halliburton
HAL
$29.4B
| $66M | 0.09% |
1,120,500
-966,000
| -46% | -$51.6M |
|
228
CALL
JPMorgan Chase
JPM
$935B
| $65.9M | 0.09% |
1,084,800
-619,600
| -36% | -$35.8M |
|
229
NCR Voyix
VYX
$1.09B
| $65.6M | 0.09% |
2,924,375
-1,365,695
| -32% | -$29M |
|
|
CELG
230
DELISTED
Celgene Corp
CELG
| $65.5M | 0.09% |
938,582
+193,080
| +26% | +$15.3M |
|
231
Goldman Sachs
GS
$303B
| $65.3M | 0.09% |
398,461
+329,281
| +476% | +$55.4M |
|
232
Delek US
DK
$4.38B
| $65.2M | 0.09% |
2,244,109
+894,109
| +66% | +$27M |
|
|
BHI
233
DELISTED
Baker Hughes
BHI
| $64.8M | 0.09% |
996,399
-274,644
| -22% | -$16.2M |
|
234
Mondelez International
MDLZ
$82.3B
| $64.7M | 0.09% |
1,873,498
+1,027,927
| +122% | +$35.1M |
|
235
CALL
Qualcomm
QCOM
$169B
| $64.4M | 0.09% |
816,600
+540,000
| +195% | +$40.7M |
|
|
FTR
236
DELISTED
Frontier Communications Corp.
FTR
| $64.2M | 0.09% |
751,002
+95,497
| +15% | +$6.99M |
|
|
LSI
237
DELISTED
LSI CORPORATION
LSI
| $63.1M | 0.09% |
5,703,267
-1,329,978
| -19% | -$14.7M |
|
238
PUT
Verizon
VZ
$205B
| $62.8M | 0.09% |
1,320,800
+498,400
| +61% | +$23.6M |
|
|
AGN
239
DELISTED
Allergan plc
AGN
| $62.7M | 0.09% |
304,570
+295,855
| +3,395% | +$58.6M |
|
240
MSCI
MSCI
$41B
| $62.4M | 0.09% |
1,450,962
+204,862
| +16% | +$8.93M |
|
241
Lear
LEA
$8.56B
| $62.3M | 0.09% |
744,210
-585,413
| -44% | -$46.6M |
|
242
PUT
Morgan Stanley
MS
$336B
| $61.6M | 0.09% |
1,975,300
-2,832,800
| -59% | -$87.5M |
|
|
WBA
243
DELISTED
Walgreens Boots Alliance
WBA
| $61.5M | 0.09% |
931,475
-991,412
| -52% | -$62.3M |
|
244
H&R Block
HRB
$6.62B
| $61.1M | 0.09% |
2,022,565
-594,160
| -23% | -$17.8M |
|
245
Trane Technologies
TT
$99.8B
| $60.6M | 0.09% |
1,058,655
-122,571
| -10% | -$7.3M |
|
|
246
Halliburton
HAL
$29.4B
| $60.5M | 0.09% |
1,027,968
+135,291
| +15% | +$7.23M |
|
247
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $60.1M | 0.09% |
200,100
-67,800
| -25% | -$20.9M |
|
248
First Solar
FSLR
$23B
| $60M | 0.09% |
860,300
-246,847
| -22% | -$13.8M |
|
249
Sensata Technologies
ST
$6.23B
| $59.9M | 0.09% |
1,405,889
-190,624
| -12% | -$7.6M |
|
250
Archer Daniels Midland
ADM
$38.7B
| $59.9M | 0.09% |
1,380,299
+459,294
| +50% | +$18.9M |
|
Similar funds
David Shaw's Q1 2014 Portfolio in Review
As of Q1 2014, David Shaw held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 9.3% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Veren worth $53.3M.
- David Shaw's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- David Shaw added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- David Shaw's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- David Shaw fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- David Shaw's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- David Shaw opened 596 new positions and closed 795 in Q1 2014.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.